Left Ventricular Mass Reduction by a Low-Sodium Diet in Treated Hypertensive Patients
Overview
Affiliations
Objective: To evaluate the left ventricular mass (LVM) reduction induced by dietary sodium restriction.
Patients And Methods: A simple sodium-restricted diet was advised in 138 treated hypertensives. They had to avoid common salt loads, such as cheese and salt-preserved meat, and were switched from regular to salt-free bread. Blood pressure (BP), 24-h urinary sodium (UNaV) and LVM were recorded at baseline, after 2 months. and after 2years.
Results: In 76 patients UNaV decreased in the recommended range after 2 months and remained low at 2 years. In 62 patients UNaV levels decreased after 2 months and then increased back to baseline at 2 years. Initially the two groups did not differ in terms of BP (134.3 ± 16.10 / 80.84 ± 12.23 vs.134.2 ± 16.67 / 81.55 ± 11.18 mmHg, mean ± SD), body weight (72.64 ± 15.17 vs.73.79 ± 12.69 kg), UNaV (161.0 ± 42.22 vs.158.2 ± 48.66 mEq/24 h), and LVM index (LVMI; 97.09 ± 20.42 vs.97.31 ± 18.91 g/m). After 2years. they did not differ in terms of BP (125.3 ± 10.69 / 74.97 ± 7.67 vs.124.5 ± 9.95 / 75.21 ± 7.64 mmHg) and body weight (71.14 ± 14.29 vs.71.50 ± 11.87 kg). Significant differences were seen for UNaV (97.3 ± 23.01 vs.152.6 ± 49.96 mEq/24 h) and LVMI (86.38 ± 18.17 vs.103.1 ± 21.06 g/m). Multiple regression analysis: UNaV directly and independently predicted LVMI variations, either as absolute values (R = 0.369; β = 0.611; < 0.001), or changes from baseline to +2years. (R = 0.454; β = 0.677; < 0.001). Systolic BP was a weaker predictor of LVMI (R = 0.369; β = 0.168; = 0.027; R = 0.454; β = 0.012; = 0.890), whereas diastolic BP was not correlated with LVMI. The prevalence of left ventricular hypertrophy decreased (29/76 to 15/76) in the first group while it increased in the less compliant patients (25/62 to 36/62; Chi = 0.002).
Conclusion: LVM seems linked to sodium consumption in patients already under proper BP control by medications.
Jv M, Zhang J, Han Y, Yang A, Zhu Y Eur J Med Res. 2024; 29(1):627.
PMID: 39726054 PMC: 11670427. DOI: 10.1186/s40001-024-02234-3.
Matthews E, Guers J, Ramick M, Hosick P Healthcare (Basel). 2024; 12(3).
PMID: 38338238 PMC: 10855375. DOI: 10.3390/healthcare12030353.
Genovesi S, Tassistro E, Giussani M, Antolini L, Lieti G, Orlando A Pediatr Nephrol. 2023; 38(12):4069-4082.
PMID: 37349569 PMC: 10584714. DOI: 10.1007/s00467-023-06034-5.
Liu J, Yang X, Zhang P, Guo D, Xu B, Huang C Front Endocrinol (Lausanne). 2021; 12:728493.
PMID: 34650519 PMC: 8505965. DOI: 10.3389/fendo.2021.728493.
Sodium Intake and Target Organ Damage in Hypertension-An Update about the Role of a Real Villain.
Nista F, Gatto F, Albertelli M, Musso N Int J Environ Res Public Health. 2020; 17(8).
PMID: 32325839 PMC: 7215960. DOI: 10.3390/ijerph17082811.